Pharma stocks fell after Trump said US drug import tariffs would rise to 250% over 18 months to boost local production. The Nifty Pharma index dropped 1.5%, led by declines in Ajanta, Zydus, and Glenmark. India's pharma exports to the US stood at $8.7 billion in FY24. Retail sentiment turned bearish amid ongoing tariff tensions.